Trial intelligence / Profile preview

High-dose versus low-dose atorvastatin preconditioning before CABG

IRCT2017080619470N61Phase 4Completed

Sponsor
Shiraz University of Medical Sciences
Start
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of atorvastatin in coronary arteriosclerosis (2 arms), sponsored by Shiraz University of Medical Sciences. Started Apr 2013; status: completed.

02

Drugs

atorvastatin
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on IRCT2017080619470N61.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017080619470N61.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call